IP Library Assignment 055010/0696
Patent Assignment
Reel/Frame 055010/0696

Release of Security Interest

Recorded: 2021-01-23 Pages: 12
Assignor
KREOS CAPITAL V (UK) LIMITED
Executed: 2020-12-15
Assignee
MEREO BIOPHARMA 1 LIMITED
1 CAVENDISH PLACE, LONDON, W1G 0QF, UNITED KINGDOM
Covered Properties (2)
Dosage Regimen for the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Application: 16/082,765 →
Publication: US 2019/0060279
Dosage Regimen for the Treatment of Acute Exacerbations of Inflammatory Conditions
Application: 16/082,772 →
Publication: US 2019/0091203
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Nov 7, 2018
From: MEREO BIOPHARMA 1 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 047446/0556 →
Assignment of Assignor's Interest Sep 27, 2019
From: CLARKE, CYRIL; FARRELL, COLM; PARKIN, JACQUELINE; ORFORD, COLIN
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 050527/0773 →
Assignment of Assignor's Interest Sep 27, 2019
From: DE BUCK, STEFAN
To: NOVARTIS PHARMA AG
Reel/Frame 050527/0807 →
Assignment of Assignor's Interest Sep 27, 2019
From: NOVARTIS PHARMA AG
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 050527/0834 →
Release of Security Interest Jan 23, 2021
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMINTED
Reel/Frame 055010/0654 →